Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Safety, Tolerability and Pharmacokinetics 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol in Healthy Subjects

Next Previous
Trial Profile

A Randomized, Safety, Tolerability and Pharmacokinetics 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fosfomycin (Primary) ; Fosfomycin tromethamine
  • Indications Pseudomonal infections
  • Focus Adverse reactions; Pharmacokinetics

Most Recent Events

  • 08 Oct 2017 Outcomes of population pharmacokinetic analysis (refinement) of ZTI-01 using pooled data from healthy subjects (NCT02178254) and patients (NCT02753946) with complicated urinary tract infections, presented at the IDWeek 2017.
  • 05 Jun 2017 According to the Zavante Therapeutics media release, results from the study were be presented at the ASM Microbe 2017.
  • 17 May 2017 According to the Zavante Therapeutics media release, data from the study will be presented at the ASM Microbe 2017.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top